Message from the President
Riding the horse year into 2014, we are anticipating a special and successful year! On the wave of this special time, we are preparing for our SABPA 9th Annual Biomedical Forum on Saturday, April 26th, 2014 in Crowne Plaza Hotel in Costa Mesa, CA. The Annual Biomedical Forum is the flagship event of our SABPA OC/LA chapter. It gathers elite speakers from academics, industries, IP law experts, and investors from both the United States and China. The topics will cover a broad range of subjects, including drug discovery, diagnostics, micro implants for eyes, cardiovascular medical devices, personalized medicine, bio-3D printing, IP protection, and medical devices in China. We are very excited about this year’s program and expect a highly successful event.
On behalf of SABPA, I encourage you all to join this forum and take this opportunity to learn, share, and network among our scientists, engineers, investors, executives, students, entrepreneurs, and policy makers in order to promote life sciences, biotech, medical device, pharmaceutical, and alliances across the biomedical industry in southern California and Asian countries.
I am also pleased to update all SABPA OC/LA members that 2013 was a very successful year. We have further established our committees and volunteer teams with involvement from enthusiastic members, particularly those from universities in the OC/LA area. All committee chairs took the initiative to build their teams and completed all their responsible tasks. As a result of the efforts from these dedicated committee members and volunteers, we successfully organized our 2013 SABPA 8th Annual Biomedical Forum with more than 200 attendees and 2013 career development workshops.
I would like to take this opportunity to thank the SABPA OC/LA committee members and volunteers for their hard work, our sponsors for their generosity, and your participations to make our forum successful. I would welcome you all to get involved and provide support to SABPA for its future development and growth.
Hope you all to enjoy the forum.
Cheers!
Yan-Bo Yang, Ph.D.
President, SABPA OC/LA
a:12:{i:0;a:3:{s:12:"time_program";s:8:"Speakers";s:19:"description_program";s:90:"Larry A. Wheeler, Ph.D. (Keynote Speaker)
Sr. VP, Biological Sciences, Allergan, Inc.";s:7:"program";s:46:"Challenges and opportunities in drug discovery";}i:1;a:3:{s:12:"time_program";s:8:"Speakers";s:19:"description_program";s:73:"Qiyi Luo (Keynote Speaker)
CTO, Shanghai Microport Medical Co., Ltd.";s:7:"program";s:80:"Innovation in interventional medical devices for the treatment of heart diseases";}i:2;a:3:{s:12:"time_program";s:8:"Speakers";s:19:"description_program";s:123:"Wei Sun, Ph.D.
Albert Soffa Chair Professor
Department of Mechanical Engineering and Mechanics, Drexel University";s:7:"program";s:47:"Bio–3D printing: Challenges and opportunities";}i:3;a:3:{s:12:"time_program";s:8:"Speakers";s:19:"description_program";s:73:"Yu-Chong Tai, Ph.D.
Prof. and Chair, Electrical Engineering, CalTech";s:7:"program";s:42:"A new generation of micro implants for eye";}i:4;a:3:{s:12:"time_program";s:8:"Speakers";s:19:"description_program";s:61:"Terry Robins, Ph.D.
President, Molecular RxDx Strategies";s:7:"program";s:75:"Personalized medicine: The future of diagnostic and pharmaceutical sciences";}i:5;a:3:{s:12:"time_program";s:8:"Speakers";s:19:"description_program";s:70:"Weian Zhao, Ph.D.
Asst. Prof., Pharmaceutical Sciences, UC Irvine";s:7:"program";s:27:"Next generation diagnostics";}i:6;a:3:{s:12:"time_program";s:8:"Speakers";s:19:"description_program";s:91:"Raymond W. Brullo, D.P.M., FAPWCA
Compliance Officer, FDA, Los Angeles District Office";s:7:"program";s:112:"Medical Devices, Drugs, Dietary Supplements: China, Resources and Violations of the Food, Drug, and Cosmetic Act";}i:7;a:3:{s:12:"time_program";s:8:"Speakers";s:19:"description_program";s:71:"Agnes Juang, Ph.D., J.D.
Partner, Knobbe Martens Olson & Bear, LLP";s:7:"program";s:28:"Avoiding patent infringement";}i:8;a:3:{s:12:"time_program";s:9:"Panelists";s:19:"description_program";s:68:"Karen Liu
Partner, KaiWu Investment (a biomedical VC in China) ";s:7:"program";s:37:"Topic: “Medical devices in China”";}i:9;a:3:{s:12:"time_program";s:9:"Panelists";s:19:"description_program";s:98:"Chang Yu, Ph.D.
President, AnPac Bio-Medical Science Co., Ltd. (a cancer diagnostic company) ";s:7:"program";s:37:"Topic: “Medical devices in China”";}i:10;a:3:{s:12:"time_program";s:9:"Panelists";s:19:"description_program";s:89:"Liguo Qiang
President, Changzhou Yanling Electronics LLC (a medical device company) ";s:7:"program";s:37:"Topic: “Medical devices in China”";}i:11;a:3:{s:12:"time_program";s:9:"Panelists";s:19:"description_program";s:92:"Daozhi Liu, Ph.D.
President, Shanghai Pudong Medical Devices Professionals Association ";s:7:"program";s:37:"Topic: “Medical devices in China”";}}
Sr. VP, Biological Sciences, Allergan, Inc.";s:7:"program";s:46:"Challenges and opportunities in drug discovery";}i:1;a:3:{s:12:"time_program";s:8:"Speakers";s:19:"description_program";s:73:"Qiyi Luo (Keynote Speaker)
CTO, Shanghai Microport Medical Co., Ltd.";s:7:"program";s:80:"Innovation in interventional medical devices for the treatment of heart diseases";}i:2;a:3:{s:12:"time_program";s:8:"Speakers";s:19:"description_program";s:123:"Wei Sun, Ph.D.
Albert Soffa Chair Professor
Department of Mechanical Engineering and Mechanics, Drexel University";s:7:"program";s:47:"Bio–3D printing: Challenges and opportunities";}i:3;a:3:{s:12:"time_program";s:8:"Speakers";s:19:"description_program";s:73:"Yu-Chong Tai, Ph.D.
Prof. and Chair, Electrical Engineering, CalTech";s:7:"program";s:42:"A new generation of micro implants for eye";}i:4;a:3:{s:12:"time_program";s:8:"Speakers";s:19:"description_program";s:61:"Terry Robins, Ph.D.
President, Molecular RxDx Strategies";s:7:"program";s:75:"Personalized medicine: The future of diagnostic and pharmaceutical sciences";}i:5;a:3:{s:12:"time_program";s:8:"Speakers";s:19:"description_program";s:70:"Weian Zhao, Ph.D.
Asst. Prof., Pharmaceutical Sciences, UC Irvine";s:7:"program";s:27:"Next generation diagnostics";}i:6;a:3:{s:12:"time_program";s:8:"Speakers";s:19:"description_program";s:91:"Raymond W. Brullo, D.P.M., FAPWCA
Compliance Officer, FDA, Los Angeles District Office";s:7:"program";s:112:"Medical Devices, Drugs, Dietary Supplements: China, Resources and Violations of the Food, Drug, and Cosmetic Act";}i:7;a:3:{s:12:"time_program";s:8:"Speakers";s:19:"description_program";s:71:"Agnes Juang, Ph.D., J.D.
Partner, Knobbe Martens Olson & Bear, LLP";s:7:"program";s:28:"Avoiding patent infringement";}i:8;a:3:{s:12:"time_program";s:9:"Panelists";s:19:"description_program";s:68:"Karen Liu
Partner, KaiWu Investment (a biomedical VC in China) ";s:7:"program";s:37:"Topic: “Medical devices in China”";}i:9;a:3:{s:12:"time_program";s:9:"Panelists";s:19:"description_program";s:98:"Chang Yu, Ph.D.
President, AnPac Bio-Medical Science Co., Ltd. (a cancer diagnostic company) ";s:7:"program";s:37:"Topic: “Medical devices in China”";}i:10;a:3:{s:12:"time_program";s:9:"Panelists";s:19:"description_program";s:89:"Liguo Qiang
President, Changzhou Yanling Electronics LLC (a medical device company) ";s:7:"program";s:37:"Topic: “Medical devices in China”";}i:11;a:3:{s:12:"time_program";s:9:"Panelists";s:19:"description_program";s:92:"Daozhi Liu, Ph.D.
President, Shanghai Pudong Medical Devices Professionals Association ";s:7:"program";s:37:"Topic: “Medical devices in China”";}}
The registration is now closed. Please check back for future SABPA events
SABPA OCLA
